NL Industries (NL) Q2 EPS Drops 94%

NL Industries reported a significant Q2 2025 GAAP EPS miss, with earnings falling to $0.01, down from $0.16 year-over-year and 94.7% below analyst estimates, driven by severe weakness in its Kronos Worldwide chemical segment. Kronos suffered an equity loss due to lower titanium dioxide prices, reduced sales volumes, and a sharp decline in plant utilization to 81% from 99%, incurring substantial unabsorbed fixed costs. While the CompX segment delivered strong performance with 12.3% net sales growth, it was insufficient to offset the core chemical business's struggles, and NL provided no forward guidance, indicating persistent uncertainty in the TiO2 market.

Analysis

NL Industries reported a severe earnings miss for Q2 2025, with GAAP EPS plummeting to $0.01, a 94.7% shortfall against the $0.19 analyst consensus and a sharp decline from $0.16 in the prior-year quarter. The negative result was almost entirely driven by substantial operational and market pressures within its principal subsidiary, Kronos Worldwide. Kronos swung to an equity loss for NL of $2.8 million, compared to a $6.0 million profit in Q2 2024, as lower titanium dioxide (TiO2) selling prices and weak export volumes were compounded by significant operational deleverage. Plant utilization at Kronos fell dramatically to 81% from 99% a year ago, resulting in $20 million of unabsorbed fixed costs that severely eroded profitability. In stark contrast, the CompX segment delivered a strong performance, with net sales increasing 12.3% to $40.3 million and segment profit growing to $6.3 million. However, this positive contribution was insufficient to offset the profound weakness in the core chemicals business. The company's decision not to issue forward guidance underscores the high degree of uncertainty surrounding a potential recovery in the global TiO2 market, which is hampered by geopolitical tensions and customer hesitancy to rebuild inventories.

Key Decisions for Investors

• Given the substantial earnings miss and severe margin compression at Kronos, investors should view NL Industries with caution, as its valuation is heavily dependent on a TiO2 market that currently shows no signs of near-term recovery.
• The key metric to monitor is Kronos's plant utilization rate; a return toward the high-90s is critical for absorbing fixed costs and restoring profitability, but until then, earnings will remain under significant pressure.
• While the CompX segment's 12.3% sales growth is a positive, its scale is insufficient to materially offset the challenges in the chemicals segment, making it an unreliable basis for a bullish thesis on the consolidated company.
• The lack of forward guidance from management signals deep uncertainty and suggests it may be prudent to await clear evidence of improving TiO2 pricing and demand before considering new or increased long positions.